SI3302573T1 - Sestavek za zdravljenje možganskih lezij - Google Patents

Sestavek za zdravljenje možganskih lezij

Info

Publication number
SI3302573T1
SI3302573T1 SI201630468T SI201630468T SI3302573T1 SI 3302573 T1 SI3302573 T1 SI 3302573T1 SI 201630468 T SI201630468 T SI 201630468T SI 201630468 T SI201630468 T SI 201630468T SI 3302573 T1 SI3302573 T1 SI 3302573T1
Authority
SI
Slovenia
Prior art keywords
treatment
composition
brain lesions
lesions
brain
Prior art date
Application number
SI201630468T
Other languages
English (en)
Inventor
Denis Barritault
Myriam Bernaudin
Omar Touzani
Jerome Toutain
Marie-Sophie Quittet
Original Assignee
Organes Tissus Regeneration Reparation Remplacement
Denis Barritault
Centre National De La Recherche Scientifique
L'universite De Caen Basse-Normandie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organes Tissus Regeneration Reparation Remplacement, Denis Barritault, Centre National De La Recherche Scientifique, L'universite De Caen Basse-Normandie filed Critical Organes Tissus Regeneration Reparation Remplacement
Publication of SI3302573T1 publication Critical patent/SI3302573T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SI201630468T 2015-05-28 2016-05-26 Sestavek za zdravljenje možganskih lezij SI3302573T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305806.0A EP3097928A1 (fr) 2015-05-28 2015-05-28 Composition pour le traitement des lesions cerebrales
EP16727364.8A EP3302573B1 (fr) 2015-05-28 2016-05-26 Composition pour le traitement des lesions cerebrales
PCT/EP2016/061905 WO2016189087A1 (fr) 2015-05-28 2016-05-26 Composition pour le traitement des lesions cerebrales

Publications (1)

Publication Number Publication Date
SI3302573T1 true SI3302573T1 (sl) 2019-12-31

Family

ID=53276045

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201630468T SI3302573T1 (sl) 2015-05-28 2016-05-26 Sestavek za zdravljenje možganskih lezij

Country Status (17)

Country Link
US (1) US20180161372A1 (sl)
EP (2) EP3097928A1 (sl)
JP (1) JP6879941B2 (sl)
KR (1) KR20180043208A (sl)
CN (1) CN107864626A (sl)
AU (1) AU2016266772A1 (sl)
CA (1) CA2992899A1 (sl)
DK (1) DK3302573T3 (sl)
ES (1) ES2755053T3 (sl)
IL (1) IL255692B (sl)
MX (1) MX2017015292A (sl)
PL (1) PL3302573T3 (sl)
PT (1) PT3302573T (sl)
RU (1) RU2710543C2 (sl)
SI (1) SI3302573T1 (sl)
WO (1) WO2016189087A1 (sl)
ZA (1) ZA201707737B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3097922A1 (fr) * 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
WO2019237106A1 (en) * 2018-06-08 2019-12-12 University Of Virginia Patent Foundation Compositions and methods for treating stroke
FR3096579B1 (fr) * 2019-05-27 2023-05-05 Organes Tissus Regeneration Reparation Remplacement composition pour la protection et la reparation de la barriere hematoencephalique (BHE)
JP2023517579A (ja) * 2020-03-09 2023-04-26 オルガンズ ティシューズ リジェネレーション リパレーション レムプレースメント - オーティーアール3 呼吸器系の病変の治療のための組成物
CN114317421B (zh) * 2021-12-16 2024-05-03 北京科技大学 强化间充质干细胞促进血管生成的方法、组合物及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573251B2 (en) * 1994-03-30 2003-06-03 Denis Barritault Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
AU2003232152A1 (en) * 2002-05-30 2003-12-19 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
FR2979110B1 (fr) * 2011-08-16 2013-09-27 Etat Francais Ministere De La Defense Service De Sante Des Armees Modelisation in vitro des niches medullaires a cellules souches hematopoietiques : un outil pour etudier la regulation de l'hematopoiese, evaluer le potentiel de nichage d'un greffon hematopoietique et tester la pharmaco-toxicologie de medicaments.

Also Published As

Publication number Publication date
PT3302573T (pt) 2019-10-29
RU2017139945A (ru) 2019-06-28
EP3302573B1 (fr) 2019-09-11
EP3097928A1 (fr) 2016-11-30
AU2016266772A1 (en) 2017-12-14
RU2017139945A3 (sl) 2019-09-04
KR20180043208A (ko) 2018-04-27
ZA201707737B (en) 2018-11-28
WO2016189087A1 (fr) 2016-12-01
MX2017015292A (es) 2018-05-02
DK3302573T3 (da) 2019-11-11
IL255692B (en) 2021-02-28
PL3302573T3 (pl) 2020-03-31
US20180161372A1 (en) 2018-06-14
IL255692A (en) 2018-01-31
JP2018516258A (ja) 2018-06-21
CA2992899A1 (fr) 2016-12-01
CN107864626A (zh) 2018-03-30
EP3302573A1 (fr) 2018-04-11
RU2710543C2 (ru) 2019-12-27
JP6879941B2 (ja) 2021-06-02
ES2755053T3 (es) 2020-04-21

Similar Documents

Publication Publication Date Title
HK1251257A1 (zh) 用於醫治疾病的外泌體的用途
HK1247202A1 (zh) 用於治療癌症的化合物
IL253945B (en) kdm1a inhibitors to treat the disease
SG11201705093UA (en) Composition for treating il-6-related diseases
IL259996A (en) Combinations for cancer treatment
HUE053654T2 (hu) FGFR- és CMET-inhibitorok kombinációi a rák kezelésére
PT3261726T (pt) Composição para o tratamento do acne
HK1252996A1 (zh) 用於治療癲癇的方法
HK1245127A1 (zh) 治療腦疾病的方法和組合物
IL255692B (en) Composition for treating brain lesions
IL249640A0 (en) Preparations for the treatment of nosebleeds
ZA201707813B (en) Composition for treating tissue lesions
GB201612043D0 (en) Composition for treatment of disorders
HK1248130A1 (zh) 用於治療疼痛的組合物
EP3362085C0 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH MUCIN
IL255167A0 (en) Compounds for the treatment of cancer
PT3340975T (pt) Formulação para o tratamento de acne
PT3307292T (pt) Formulações para o tratamento de lesões da mucosa
IL267059A (en) A preparation for the treatment of osteoarthritis
ZA201704589B (en) Compounds for the treatment of cancer
PT3524255T (pt) Composição para o tratamento do acne
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
AU2015901799A0 (en) Composition for the treatment of skin conditions